| Year |
Citation |
Score |
| 2023 |
Pomeshchik Y, Klementieva O, Gil J, Martinsson I, Hansen MG, de Vries T, Sancho-Balsells A, Russ K, Savchenko E, Collin A, Vaz AR, Bagnoli S, Nacmias B, Rampon C, Sorbi S, et al. Human iPSC-Derived Hippocampal Spheroids: An Innovative Tool for Stratifying Alzheimer Disease Patient-Specific Cellular Phenotypes and Developing Therapies. Stem Cell Reports. 18: 1244-1245. PMID 37163981 DOI: 10.1016/j.stemcr.2023.04.009 |
0.773 |
|
| 2022 |
Azevedo C, Teku G, Pomeshchik Y, Reyes JF, Chumarina M, Russ K, Savchenko E, Hammarberg A, Lamas NJ, Collin A, Gouras GK, Klementieva O, Hallbeck M, Taipa R, Vihinen M, et al. Parkinson's disease and multiple system atrophy patient iPSC-derived oligodendrocytes exhibit alpha-synuclein-induced changes in maturation and immune reactive properties. Proceedings of the National Academy of Sciences of the United States of America. 119: e2111405119. PMID 35294277 DOI: 10.1073/pnas.2111405119 |
0.683 |
|
| 2021 |
Pomeshchik Y, Klementieva O, Gil J, Martinsson I, Hansen MG, de Vries T, Sancho-Balsells A, Russ K, Savchenko E, Collin A, Vaz AR, Bagnoli S, Nacmias B, Rampon C, Sorbi S, et al. Human iPSC-derived hippocampal spheroids: An innovative tool for stratifying Alzheimer disease patient-specific cellular phenotypes and developing therapies. Stem Cell Reports. 16: 2838. PMID 34758331 DOI: 10.1016/j.stemcr.2021.10.003 |
0.773 |
|
| 2021 |
Russ K, Teku G, Bousset L, Redeker V, Piel S, Savchenko E, Pomeshchik Y, Savistchenko J, Stummann TC, Azevedo C, Collin A, Goldwurm S, Fog K, Elmer E, Vihinen M, et al. TNF-α and α-synuclein fibrils differently regulate human astrocyte immune reactivity and impair mitochondrial respiration. Cell Reports. 34: 108895. PMID 33761362 DOI: 10.1016/j.celrep.2021.108895 |
0.742 |
|
| 2020 |
Pomeshchik Y, Klementieva O, Gil J, Martinsson I, Hansen MG, de Vries T, Sancho-Balsells A, Russ K, Savchenko E, Collin A, Vaz AR, Bagnoli S, Nacmias B, Rampon C, Sorbi S, et al. Human iPSC-Derived Hippocampal Spheroids: An Innovative Tool for Stratifying Alzheimer Disease Patient-Specific Cellular Phenotypes and Developing Therapies. Stem Cell Reports. PMID 32589876 DOI: 10.1016/J.Stemcr.2020.06.001 |
0.754 |
|
| 2019 |
Chumarina M, Russ K, Azevedo C, Heuer A, Pihl M, Collin A, Frostner EÅ, Elmer E, Hyttel P, Cappelletti G, Zini M, Goldwurm S, Roybon L. Cellular alterations identified in pluripotent stem cell-derived midbrain spheroids generated from a female patient with progressive external ophthalmoplegia and parkinsonism who carries a novel variation (p.Q811R) in the POLG1 gene. Acta Neuropathologica Communications. 7: 208. PMID 31843010 DOI: 10.1186/S40478-019-0863-7 |
0.755 |
|
| 2019 |
Savchenko E, Teku GN, Boza-Serrano A, Russ K, Berns M, Deierborg T, Lamas NJ, Wichterle H, Rothstein J, Henderson CE, Vihinen M, Roybon L. FGF family members differentially regulate maturation and proliferation of stem cell-derived astrocytes. Scientific Reports. 9: 9610. PMID 31270389 DOI: 10.1038/S41598-019-46110-1 |
0.755 |
|
| 2018 |
Gustavsson N, Marote A, Pomeshchik Y, Russ K, Azevedo C, Chumarina M, Goldwurm S, Collin A, Pinto L, Salgado AJ, Klementieva O, Roybon L, Savchenko E. Generation of an induced pluripotent stem cell line (CSC-46) from a patient with Parkinson's disease carrying a novel p.R301C mutation in the GBA gene. Stem Cell Research. 34: 101373. PMID 30640063 DOI: 10.1016/J.Scr.2018.101373 |
0.711 |
|
| 2018 |
Savchenko E, Marote A, Russ K, Collin A, Goldwurm S, Roybon L, Pomeshchik Y. Generation of a human induced pluripotent stem cell line (CSC-42) from a patient with sporadic form of Parkinson's disease. Stem Cell Research. 27: 78-81. PMID 29334629 DOI: 10.1016/J.Scr.2018.01.002 |
0.805 |
|
| 2018 |
Russ K, Marote A, Savchenko E, Collin A, Goldwurm S, Pomeshchik Y, Roybon L. Generation of a human induced pluripotent stem cell line (CSC-40) from a Parkinson's disease patient with a PINK1 p.Q456X mutation. Stem Cell Research. 27: 61-64. PMID 29331938 DOI: 10.1016/J.Scr.2018.01.001 |
0.812 |
|
| 2007 |
Flores J, O'Kusky J, Russ K, Cornfeldt M, Mitrovic B, Doudet D. 3.202 Survival and host immune response of implants of human retinal pigment epithelial cells on gelatin microcarriers (hRPE-GM) (Spheramine®) in animal models of Parkinson's disease (PD) Parkinsonism & Related Disorders. 13: S161-S162. DOI: 10.1016/S1353-8020(08)70840-X |
0.342 |
|
| 2007 |
Flores J, O'Kusky J, Russ K, Cornfeldt M, Mitrovic B, Doudet D. 3.018 Survival and host immune response of implants of human retinal pigment epithelial cells on gelatin microcarriers (hRPE-GM) (Spheramine®) in animal models of Parkinson's disease (PD) Parkinsonism & Related Disorders. 13: S150. DOI: 10.1016/S1353-8020(08)70802-2 |
0.342 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2016 |
Russ K, Flores J, Brudek T, Doudet D. Neonatal human retinal pigment epithelial cells secrete limited trophic factors in vitro and in vivo following striatal implantation in parkinsonian rats. Journal of Neural Transmission (Vienna, Austria : 1996). 123: 167-77. PMID 26546037 DOI: 10.1007/s00702-015-1480-7 |
0.168 |
|
| 2017 |
Russ K, Flores J, Brudek T, Doudet DJ. Differential behavioral outcomes following neonatal versus fetal human retinal pigment epithelial cell striatal implants in parkinsonian rats. Journal of Neural Transmission (Vienna, Austria : 1996). PMID 28160153 DOI: 10.1007/s00702-017-1683-1 |
0.144 |
|
| 2007 |
Vogelsang TW, Jensen RJ, Monrad AL, Russ K, Olesen UH, Hesse B, Kjaer A. Independent effects of both right and left ventricular function on plasma brain natriuretic peptide. European Journal of Heart Failure. 9: 892-6. PMID 17613272 DOI: 10.1016/j.ejheart.2007.05.015 |
0.038 |
|
| Hide low-probability matches. |